COVID-19 Associated Atrial Fibrillation: Incidence, Putative Mechanisms and Potential Clinical Implications

Overview

Journal Int J Cardiol Heart Vasc

Date 2020 Sep 9

PMID 32904969

Citations 87

Authors

Monika Gawalko

Agnieszka Kaplon-Cieslicka

Mathias Hohl

Dobromir Dobrev

Dominik Linz

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients.

Citing Articles

Temporal variations in QTc interval during and after COVID-19 infection: a retrospective study.

Lu D, Hu J, Qian J, Cheng F BMC Cardiovasc Disord. 2024; 24(1):738.

PMID: 39710654 PMC: 11664898. DOI: 10.1186/s12872-024-04405-w.

Are Pre-Hospitalization ECG Abnormalities Associated With Increased Mortality in COVID-19 Patients? A Quantitative Systematic Literature Review.

Askey D, Smith A Ann Noninvasive Electrocardiol. 2024; 29(6):e70016.

PMID: 39394768 PMC: 11470194. DOI: 10.1111/anec.70016.

Inflammation and Atrial Fibrillation: An Exclusive Association or an Accomplice to the Cardiovascular Continuum of Additional Risk Factors?.

Darrieux F Arq Bras Cardiol. 2024; 121(6):e20240382.

PMID: 39166545 PMC: 11364447. DOI: 10.36660/abc.20240382.

Impact of COVID-19 infection on the in-hospital outcome of patients hospitalized for heart failure with comorbid atrial fibrillation: Insight from the National Inpatient Sample (NIS) database 2020.

Wattanachayakul P, Suenghataiphorn T, Srikulmontri T, Rujirachun P, Malin J, Danpanichkul P J Arrhythm. 2024; 40(4):895-902.

PMID: 39139900 PMC: 11317655. DOI: 10.1002/joa3.13071.

COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation.

Yang L, Tang S, Guo J, Gabriel N, Gellad W, Essien U Am J Cardiovasc Drugs. 2024; 24(5):693-702.

PMID: 39136872 DOI: 10.1007/s40256-024-00671-3.

References

Delle Karth G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M . Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med. 2001; 29(6):1149-53. DOI: 10.1097/00003246-200106000-00011. View

Ambrus D, Benjamin E, Bajwa E, Hibbert K, Walkey A . Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome. J Crit Care. 2015; 30(5):994-7. PMC: 4681683. DOI: 10.1016/j.jcrc.2015.06.003. View

Denham N, Pearman C, Caldwell J, Madders G, Eisner D, Trafford A . Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure. Front Physiol. 2018; 9:1380. PMC: 6180171. DOI: 10.3389/fphys.2018.01380. View

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z . Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18(5):1094-1099. PMC: 9906401. DOI: 10.1111/jth.14817. View

Thanassoulis G, Massaro J, ODonnell C, Hoffmann U, Levy D, Ellinor P . Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010; 3(4):345-50. PMC: 2953855. DOI: 10.1161/CIRCEP.109.912055. View

Seizer P, Gawaz M, May A . Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases. Cardiovasc Res. 2014; 102(1):17-23. DOI: 10.1093/cvr/cvu035. View

Simoes E Silva A, Teixeira M . ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis. Pharmacol Res. 2016; 107:154-162. DOI: 10.1016/j.phrs.2016.03.018. View

Gopinathannair R, Merchant F, Lakkireddy D, Etheridge S, Feigofsky S, Han J . COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020; 59(2):329-336. PMC: 7268965. DOI: 10.1007/s10840-020-00789-9. View

Chen Z, Mi L, Xu J, Yu J, Wang X, Jiang J . Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis. 2005; 191(5):755-60. PMC: 7110046. DOI: 10.1086/427811. View

10.

Luan Y, Guo Y, Li S, Yu B, Zhu S, Li S . Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease. Europace. 2010; 12(12):1713-8. DOI: 10.1093/europace/euq321. View

11.

Ratajczak M, Kucia M . SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells. Leukemia. 2020; 34(7):1726-1729. PMC: 7262681. DOI: 10.1038/s41375-020-0887-9. View

12.

Andrade J, Khairy P, Dobrev D, Nattel S . The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014; 114(9):1453-68. DOI: 10.1161/CIRCRESAHA.114.303211. View

13.

Linz D, Elliott A, Hohl M, Malik V, Schotten U, Dobrev D . Role of autonomic nervous system in atrial fibrillation. Int J Cardiol. 2018; 287:181-188. DOI: 10.1016/j.ijcard.2018.11.091. View

14.

Kochi A, Tagliari A, Forleo G, Fassini G, Tondo C . Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020; 31(5):1003-1008. PMC: 7262150. DOI: 10.1111/jce.14479. View

15.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

16.

Taha M, Alsafi W, Taha M, ElJack A, Ibrahim H . Coronavirus Disease and New-Onset Atrial Fibrillation: Two Cases. Cureus. 2020; 12(5):e8066. PMC: 7290110. DOI: 10.7759/cureus.8066. View

17.

Hu W, Xie J, Zhu T, Meng G, Wang M, Zhou Z . Serum N-Acetylneuraminic Acid Is Associated with Atrial Fibrillation and Left Atrial Enlargement. Cardiol Res Pract. 2020; 2020:1358098. PMC: 7174944. DOI: 10.1155/2020/1358098. View

18.

Dobrev D, Aguilar M, Heijman J, Guichard J, Nattel S . Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol. 2019; 16(7):417-436. DOI: 10.1038/s41569-019-0166-5. View

19.

Krijthe B, Heeringa J, Kors J, Hofman A, Franco O, Witteman J . Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study. Int J Cardiol. 2013; 168(6):5411-5. DOI: 10.1016/j.ijcard.2013.08.048. View

20.

Long Q, Tang X, Shi Q, Li Q, Deng H, Yuan J . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020; 26(8):1200-1204. DOI: 10.1038/s41591-020-0965-6. View